Allopurinol Initiation and All-Cause Mortality Among Patients With Gout and Concurrent Chronic Kidney Disease : A Population-Based Cohort Study

Apr-22

Nephrology Pharmacoepidemiology Rheumatology

AUTHORS : Prof Guanghua Lei, Department of Orthopaedics, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha, Hunan 410008, China – Email: lei_guanghua@csu.edu.cn – Profile: https://www.xiangya.com.cn/english/ezj_info.aspx?id=134&chn=3420 OR Dr Yuqing Zhang, Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, Boston, MA 02114, USA – Email: yzhang108@mgh.harvard.edu – Profile: https://advances.massgeneral.org/contributors/contributor.aspx?id=1566

JOURNAL : Annals of Internal Medicine

REFERENCE: 175(4):461-470

DOI : 10.7326/M21-2347

Allopurinol Initiation and All-Cause Mortality Among Patients With Gout and Concurrent Chronic Kidney Disease : A Population-Based Cohort Study

More publications

Characteristics, risk factors and clinical impact of penicillin and other antibiotic allergies in adults in the UK General Practice: a population-based cohort study

Glucose Lowering through Weight management (GLoW): a randomised controlled trial of the clinical and cost effectiveness of a diabetes education and behavioural weight management programme vs a diabetes education programme in adults with a recent diagnosis of type 2 diabetes

Target Serum Urate Achievement and Chronic Kidney Disease Progression in Patients With Gout and Kidney Disease